The Prospect of Apply Improved Papanicolaou Smear and High-risk Human Papillomavirus Detection for Shenzhen Women Cervical Cancer Screening
Guoping WANG,Fang HE,Ruifang WU
DOI: https://doi.org/10.3969/j.issn.1006-6233.2015.03.028
2015-01-01
Abstract:Objective:To study the prospect of apply improved papanicolaou smear ( Pap) by improved take-samples and high-risk human papillomavirus detection for Shenzhen women cervical cancer screening . Method:Conventional Pap smear by improving take-samples and hybrid capture Ⅱ human papillomavarus ( HC-ⅡHPV) test were performed in odd number women , LCT and HC-ⅡHPV test were performed in even number women ,Total 1000 women in study with 30~59 years old no any cervical screening in 3 yeals in Shenzhen from Feb.2012 to Jul.2012.The women with HPV-positive, Pap≥atypical squamous cells of un-determined sign ( ASCUS ) or LCT≥ASCUS received multi-spot biopsy under colposcopy .Result: In the study, Pap-positive, LCT-positive and HPV-positive were 50, 57 and 220 cases, respectively.A total of 213 women received biopsy in the study .97 cases had cervical intraepithelial neoplasia ( CIN)Ⅰ, 23 cases had CINⅡ,37 cases had CINⅢ, 3 cases had cervical cancer , 40 cases had chronic cervititis and metapla-sia.The sensitivity,specificity, negative predicted value , Youden's index of Pap was 63.2%,94.43%,96. 9%,0.58, respectively.The corresponding index of LCT was 76.0%,92.0%,98.7%,0.64, respectively.The corresponding index of HPV was 96.8%,85.0%,98.5%,0.82, respectively.The corresponding index of Pap-HPV parallel test was 100.0%,83.3%,100.0%,0.83 respectively.The corresponding index of LCT-HPV parallel test was 100.0%,83.2%,100.0%,0.83, respectively.The corresponding index of Pap-HPV parallel test was 60.5%,95.9%,96.7%,0.56, respectively.The corresponding index of Pap-HPV serial test was 72. 0%,94.3%,98.5%,0.66, respectively.The receiver operating characteristic (ROC)of Pap, LCT, HPV, Pap-HPV parallel test, LCT-HPV parallel test, Pap-HPV serial test, Pap-HPV serial test was 0.788, 0. 840, 0.910, 0.917, 0.916, 0.782, 0.832, respectively.The ROC of Pap-HPV parallel test was the highest . The cost-effectiveness ratio of Pap-HPV parallel test was best test .Conclusion: The Pap-HPV parallel screening test is best apply prospect in the study for Shenzhen women cervical cancer screening .